RE: New Job Position - Operations Site Manager09 May 2021 16:49
AZs top man is French is he not and we have a close connection with them. It would not surprise me if GM was a colleague and this guy could open a few doors for us hopefully. GM is our Popeye aka Gene Hackman in The French Connection. lol
RE: 20/30 Labs, partnered with Nonacus08 May 2021 15:23
ShaunP: Who are Nonacus? They sound an interesting company.
BIRMINGHAM, England--(BUSINESS WIRE)--Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, today announced the commercial launch of a new service for Whole Genome Sequencing of SARS-CoV-2, developed to enable the UK government’s Test-To-Release scheme. Assay development for the new service was funded by a grant from Innovate UK, the UK’s innovation agency.
Government regulations, recently announced, set out the minimum standards that private sector providers must meet for SARS-CoV-2 tests for people arriving in England. All international arrivals to the UK are required to take a test on day 2 and day 8 of their quarantine period for variant surveillance. Day 2 samples shown to be positive from qRT-PCR testing will have the SARS-CoV-2 genomes sequenced to look for novel variants. Nonacus’ new service will support this scheme and enable monitoring of the disease.
During the pandemic, Nonacus expanded its accredited service facility to support a complete SARS-CoV-2 testing workflow and developed the new rapid Whole Genome Viral Sequencing library approach with nanopore sequencing.
Chris Sale, CEO of Nonacus, said: “We are proud to have developed this service and support the government’s test-to-release scheme. Our method will provide a faster, lower cost offering for Whole Genome Viral Sequencing, which will be key in identifying and monitoring variants. We look forward to supporting laboratories undertaking SARS-CoV-2 testing, as well as aiding public health institutions in their surveillance of the virus.”
RE: New Synairgen CCO (hired in Dec 2020)08 May 2021 10:08
The CCO is certainly a useful addition to the family on various fronts and a TO is certainly within the bounds of possibility. I agree with others that it's surprising there has been no mention of this important appointment. One thing I noticed in the last rather unimpressive webinar was that RM did not seem his usual ebullient self and he appeared a little ill at ease or was this simply my imagination. Perhaps silly to read anything into this but one does wonder if change is afoot.
This has got to be the lightest day chatwise...07 May 2021 16:21
... for many months. Perhaps we have finally talked the subject to death realising the SP aint going to move however much we huff and we puff until either a new contract of sorts, news on the DHSC contract, acquisition or end June results lands. Silence is golden perhaps. Enjoy the weekend folks - brighter days are ahead methinks...
RE: NovaTalk: COVID-19 Mutations, the Ultimate Test07 May 2021 15:14
'webinar, very informative.....the share price should be well North of £15.00...what a company, sounds like we have all the right irons in the fire!' Spot on Neilrich3! If anyone remains unconvinced about the future of NCYT please watch this webinar!
RE: NovaTalk: COVID-19 Mutations, the Ultimate Test07 May 2021 15:11
They all agreed that Covid will be with us for a VERY long time owing in part to the differing strategies of numerous countries (not forgetting the cost) and that vaccines do not prevent spread of virus. They agreed that faster, more clever testing was necessary nearer to the patient (as opposed to sending tests to a lab) and also that the period of quarantine should be longer!
... we have a BLUE day with a surplus of buys. Let's hope we have reached a turning point and I for one am looking forward greatly to the next 6 weeks starting with the webinar tomorrow! We all deserve a break!
Van V. My view is that LTH's here value your comments and I certainly look forward to your more constructive posts. I think many of us are more discerning of some shall we say dubious posters than you many think . I have you down as one of The Magnificent Seven contributors whose views I often value but may not always agree with, as opposed to The Dirty Dozen, many of whom are now in my green box. I echo Wilson63's comments and respectively urge you to concentrate on your undoubted insightfulness regarding this company. The next six weeks or so could prove an incredibly exciting time for long suffering Nova shareholders many of whom are sitting on uncomfortable losses so we need a steady hand on the tiller. I just hope it's not all hands to the pump!
Would one be right to assume that...05 May 2021 10:53
... should there be a positive result re DHSC contract , within the next week or so that this is likely to be quickly published as a RNS being of a material nature. Conversely, looking on the black side, if the result for NCYT is bad would any RNS be delayed and included in the end of June RNS with potential other better news hence limiting further damage to the SP? Clutching at straws I know but this is one of the few areas other than a new contract say that could reverse the downward trend.
... as he is down exactly £4 a share from his last share purchase - a paper loss of £243500 not that this is any consolation to the bulk of his shareholders. Let's hope it may make him review whether AIM is the best vehicle for NCYT!
... at this rate we are looking at a SP of £2 or so by end of June as life returns to normal in many parts of the world. It looks as if either a new contract elsewhere or settlement with the DHSC before then can stop the rot. Fortune favours the brave.